# University of Southern California (USC) Radioactive Drug Research Committee #36 – FDA Inspection, Jul 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/university-of-southern-california-usc-radioactive-drug-research-committee-36/9cc9b5ec-bde5-4802-aeb9-2a7c790a21b6
Source feed: FDA_Inspections

> FDA inspection 1059930 of University of Southern California (USC) Radioactive Drug Research Committee #36, July 25, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 361. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059930
- Company Name: University of Southern California (USC) Radioactive Drug Research Committee #36
- Inspection Date: 2018-07-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [Company Rep](https://www.keypedia.com/people/angela-shepas/743113c1-799b-44e9-9422-8049c476bfd2)
- Issuing Officer

Company: https://www.keypedia.com/companies/university-of-southern-california-usc-radioactive-drug-research-committee-36/83e72b0c-dcf8-4b05-a1c1-98084267bc03

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c